Andrea Antinori

Research interests

Publications

• Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022

  Eurosurveillance · 2022 · 10.2807/1560-7917.es.2022.27.22.2200421

• Monkeypox virus isolation from a semen sample collected in the early phase of infection in a patient with prolonged seminal viral shedding

  The Lancet Infectious Diseases · 2022 · 10.1016/s1473-3099(22)00513-8

• Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022

  New England Journal of Medicine · 2022 · 10.1056/nejmoa2207323

• Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study

  eLife · 2021 · 10.7554/elife.67569

• ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population

  European Journal of Human Genetics · 2020 · 10.1038/s41431-020-0691-z

• Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study

  Nutrition Metabolism and Cardiovascular Diseases · 2020 · https://doi.org/10.1016/j.numecd.2020.07.031

• Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19)

  Cell Death and Differentiation · 2020 · 10.1038/s41418-020-0572-6

• Durable Efficacy of Dolutegravir Plus Lamivudine in Antiretroviral Treatment–Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI-1 and GEMINI-2 Randomized Clinical Trials

  JAIDS Journal of Acquired Immune Deficiency Syndromes · 2019 · 10.1097/qai.0000000000002275

• Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

  The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(19)30418-0

• Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

  The Lancet · 2018 · https://doi.org/10.1016/s0140-6736(18)32462-0

• Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial

  The Lancet · 2017 · 10.1016/s0140-6736(17)32340-1

• Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

  The Lancet Infectious Diseases · 2016 · 10.1016/s1473-3099(15)00536-8

• CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study

  The Lancet HIV · 2015 · 10.1016/s2352-3018(15)00006-5

• Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study

  The Lancet · 2014 · 10.1016/s0140-6736(14)60084-2

• All-cause mortality in treated HIV-infected adults with CD4 >=500/mm3 compared with the general population: evidence from a large European observational cohort collaboration

  International Journal of Epidemiology · 2011 · 10.1093/ije/dyr164

• Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

  The Lancet Infectious Diseases · 2011 · https://doi.org/10.1016/s1473-3099(11)70032-9

• Late presentation of HIV infection: a consensus definition

  HIV Medicine · 2010 · https://doi.org/10.1111/j.1468-1293.2010.00857.x

• Persistence of Neuropsychologic Deficits Despite Long-Term Highly Active Antiretroviral Therapy in Patients With HIV-Related Neurocognitive Impairment

  JAIDS Journal of Acquired Immune Deficiency Syndromes · 2007 · 10.1097/qai.0b013e318042e1ee

• Updated research nosology for HIV-associated neurocognitive disorders

  Neurology · 2007 · https://doi.org/10.1212/01.wnl.0000287431.88658.8b

• Depressive Symptoms, Neurocognitive Impairment, and Adherence to Highly Active Antiretroviral Therapy Among HIV-Infected Persons

  Psychosomatics · 2004 · 10.1176/appi.psy.45.5.394

• Correlates and Predictors of Adherence to Highly Active Antiretroviral Therapy: Overview of Published Literature

  JAIDS Journal of Acquired Immune Deficiency Syndromes · 2002 · 10.1097/00126334-200212153-00007

• Depression Is a Risk Factor for Suboptimal Adherence to Highly Active Antiretroviral Therapy

  JAIDS Journal of Acquired Immune Deficiency Syndromes · 2002 · 10.1097/00126334-200212153-00010

• Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA)

  AIDS · 2002 · https://doi.org/10.1097/00002030-200202150-00008

• Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy

  AIDS · 2001 · https://doi.org/10.1097/00002030-200108170-00005

• Self-Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV Infection

  JAIDS Journal of Acquired Immune Deficiency Syndromes · 2001 · 10.1097/00042560-200112150-00006

• Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients

  AIDS · 2000 · https://doi.org/10.1097/00002030-200003310-00005

• The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells.

  PubMed · 1998 · https://doi.org/10.1182/blood.v92.3.1011

• Diagnosis of AIDS-related focal brain lesions

  Neurology · 1997 · 10.1212/wnl.48.3.687

Current projects

No projects listed.